Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Current Neuropharmacology(1)
Expert Review of Neurotherapeutics(1)
Frontiers in Bioscience - Landmark(1)
International Journal of Biochemistry and Cell Biology(1)
Journal of Alzheimer's Disease(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(3)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(5)
ODS 10: Reducción de las desigualdades(4)
ODS 17: Alianzas para lograr los objetivos(1)
Origen
scopus(5)
Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models
ArticleAbstract: The neuroinflammatory process is thought to contribute to the progression of neurological disordersPalabras claves:Alzheimer's, apoptosis, APP/PS1, c-Jun, HIF-1αAutores:Antoni Camins, Auladell C., Brox S., de la Torre A.V., De Lemos M.L., Folch J., Lazarowski A., Pallás M., Petrov D., Zárate C.B.Fuentes:scopusTranslational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America
ReviewAbstract:Palabras claves:Autores:Antoni Camins, Britton G.B., Garcia-Cairasco N., Lazarowski A., MacCioni R.B., Palacios A., Rao K.S.J., Rocha Arrieta L.L.Fuentes:scopusUnderstanding the role of hypoxia inducible factor during neurodegeneration for new therapeutics opportunities
ReviewAbstract: Neurodegeneration (NDG) is linked with the progressive loss of neural function with intellectual andPalabras claves:HIF-1, MDR-1, Neuro-EPO, Neurodegeneration, neuroprotection, Refractory epilepsyAutores:Antoni Camins, Folch J., Lazarowski A., Merelli A., Regueiro M.R., Rodríguez J.C.G.Fuentes:scopusRole of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration
ReviewAbstract: Chemoconvulsants that induce status epilepticus in rodents have been widely used over the past decadPalabras claves:apoptosis, C-Jun N-terminal kinase signaling pathway, hippocampus, Kainic acid, neuroprotection, ReviewAutores:Antoni Camins, Auladell C., Busquets O., De Lemos M.L., Ettcheto M., Folch J., Lazarowski A., Olloquequi J., Verdaguer E., Zárate C.B.Fuentes:scopusMasitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopus